Income statement, balance sheet and cash flow statement for the last 3 fiscal years, taken from the XBRL data CALLAN JMB INC. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2024
FY2024
FY2025
Revenue
13.2
6.56
5.72
Cost of revenue
7.55
4
3.62
Gross profit
5.65
2.56
2.1
Selling, general and administrative
3.45
4.84
8.6
Operating income
2.2
-2.27
-7.03
Interest expense
0.01
0.01
0
Interest income
0.01
0.01
0.01
Other non-operating income
0
0.01
-0.93
Pre-tax income
2.2
-2.27
-7.97
Income tax
0.02
0.03
-0
Net income
2.18
-2.29
-7.97
EBITDA
2.3
-2.13
-6.88
EPS, basic
-0.87
-1.82
EPS, diluted
-0.87
-1.82
Shares, basic (weighted)
2.63
4.38
Shares, diluted (weighted)
2.63
4.38
Balance sheet
FY2024
FY2024
FY2025
Cash and equivalents
5.16
2.1
2.13
Receivables
2.9
0.62
0.34
Inventory
0.11
0.16
0.24
Other current assets
0.24
0.28
0.34
Total current assets
8.45
3.32
3.06
Property, plant and equipment
0.97
0.88
0.8
Lease right-of-use assets
0.28
0.88
1.92
Total assets
9.71
5.08
5.78
Accounts payable
0.42
0.37
0.56
Accrued liabilities
0.51
0.5
Deferred revenue
0.01
0.09
Short-term debt
0.02
0
Total current liabilities
0.77
1.27
1.41
Lease liabilities
0.13
0.63
1.66
Total liabilities
0.91
1.91
3.45
Paid-in capital
5.46
12.6
Retained earnings
-2.29
-10.3
Shareholders' equity
8.8
3.17
2.33
Total equity
8.8
3.17
2.33
Total liabilities and equity
9.71
5.08
5.78
Shares outstanding
0
3
4.86
Cash flow statement
FY2024
FY2024
FY2025
Net income
2.18
-2.29
-7.97
Depreciation and amortization
0.1
0.14
0.15
Stock-based compensation
1.56
Change in receivables
4.67
2.41
0.05
Change in inventory
-0.04
-0.04
-0.08
Change in payables
-0.25
0.46
0.19
Cash from operations
7
0.54
-4.55
Capital expenditures
-0.49
-0.05
-0.62
Cash from investing
-0.49
-0.05
-0.62
Debt repaid
-0.13
-0.1
Dividends paid
-7.4
-3.33
Cash from financing
-7.54
-3.55
5.2
Net change in cash
-1.04
-3.06
0.03
Free cash flow
6.51
0.49
-5.16
Interest paid
0.01
0.01
0
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $2.21 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
39.9%
Gross profit / revenue.
Operating margin
-146.1%
Operating income / revenue.
EBITDA margin
-143.2%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-192.0%
Pre-tax income / revenue.
Net margin
-192.0%
Net income / revenue.
FCF margin
-93.1%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-88.4%
Cash from operations / revenue.
Return on equity (ROE)
-1,433.0%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-219.5%
Net income / average total assets.
SG&A / revenue
175.4%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
29.8%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
4.7%
Capital expenditures / revenue.
D&A / revenue
2.9%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-12.8%
Revenue vs the same period a year earlier. Only from a positive base.
Gross profit growth, 1y
-17.9%
Gross profit vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y
-941.4%
Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y
-1,145.0%
Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y
-26.6%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
13.6%
Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y
66.5%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.30x
Current assets / current liabilities.
Quick ratio
0.81x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.62x
(Cash + short-term investments) / current liabilities.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$1.73
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$0.90
Revenue / diluted weighted shares.
FCF per share
-$0.84
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.80
Cash from operations / diluted weighted shares.
Book value per share
$0.12
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
2.50x
Market cap / revenue.
P/B
18.6x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
18.6x
Market cap / tangible book value, when positive.
EV/Sales
2.33x
Enterprise value / revenue.
FCF yield
-37.3%
Free cash flow / market cap.
Earnings yield
-76.9%
Net income / market cap (the inverse of P/E).
What was CALLAN JMB INC.'s revenue in fiscal 2025?
CALLAN JMB INC. reported revenue of $5.7M for fiscal 2025, 12.8% lower than the year before.
Was CALLAN JMB INC. profitable in fiscal 2025?
No. It reported a net loss of $8.0M.
How much free cash flow did CALLAN JMB INC. generate in fiscal 2025?
Cash from operations of $4.5M minus capital expenditures of $616.9K left free cash flow of -$5.2M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.